Regenazone Inc.
Exosome Treatments

About Exosome Therapy

Exosomes are small vesicles that are secreted by the body’s cells. Exosomes contain substantial amounts of growth factors, cytokines and other highly regenerative substances that can be conferred to other cells due to their unique structure.

This structure allows the exosomes to fuse with other cells in the body releasing their content into other cells. The contents of the exosomes such as cytokines, growth factors and mRNA can then help the cell heal itself due to the actions of the transferred signaling molecules.

Different from other cells, exosomes do not replicate themselves, do not contain DNA data, nor do they elicit an immune response. This results in a much safer product by comparison. By definition, exosome products are cell free and, therefore, do not contain any amount of live cells.

Get a Free Consultation

    A Source of Healing

    Stem cell derived exosomes have been shown to be the source of healing in stem cell treatments. The process for which stem cell products heal the body is as follows:

    An injured tissue releases chemical markers signaling their damage > a stem cell absorbs these markers and creates the appropriate components for healing the tissue > the stem cell packages these components into a vesicle called an exosome > the exosome goes to the site of injured tissue and attaches > the exosome releases its contents to the injured tissue, healing the tissue.

    Stem Cell derived exosomes have been shown to be efficacious in a number of studies related to repair of peripheral nerve damage, traumatic brain injury, accelerated wound healing and bone fusion, tissue repair, anti-inflammatory effects, skin regeneration, cartilage regeneration, treatment for injured ligaments/tendons, osteoarthritis, bone regeneration, and vaginal rejuvenation and much more.

    Due to the high medical risks of using live stem cells, they have been highly regulated. Currently, the only legal way to use live stem cells is if they are derived from the patient themselves or are not manipulated in any way and used as a tissue transplant. These current methods of using live stem cells have major shortcomings beyond the health risk.

    First, any tissue that is used as a transplant is limited in its application in only being able to be applied to similar tissue (placenta membranes may only be used on similar skin type tissues).

    Second, any self-derived stem cells are subject to degradation due to aging. At the age of 40 a person’s stem cells begin to lose effectiveness. By the age of 60, the age of most patients needing stem cell treatments, the stem cells are barely effective, if at all.

    We combat this by using a placenta from a new birth and extracting the mesenchymal stem cells. This allows us to use the newest and most potent stem cells possible. We then screen and culture them in a lab to control safety and efficacy of the cells. We then immerse them in the appropriate medium which allows them to secrete exosomes with consistent and high quantities of regenerative factors.

    Finally, we extract the exosomes and analyze them through batch testing at which point they are made available for research purposes.

    We have developed these stem cell derived exosomes and we have the first and only registered Biological Drug Masterfile with the FDA for MSC exosomes.

    Each dosage contains from 20 billion exosomes to 40 billion exosomes to 100 billion exosomes as the regenerative properties of these stem cell derived exosomes is remarkable.

    DynaCord

    Dynacord is the first lab in the United States to complete a Drug Masterfile with the FDA

    The FDA Master File is the submission of information to the FDA that provides confidential, detailed information to the FDA about the facilities, processes, or articles used in the manufacture, processing, packaging, or storing of one or more regulated products. (our proprietary secrets)

    * Dynacord is currently the only company selling exosomes for investigational use under an FDA Masterfile and is pursuing

    multiple Investigational New Drug Trials (INDs) as well as an FDA EUA for Long Haul Covid-19 therapy.

    * Dynacord MSC exosomes are manufactured to the same standards as a drug. In other words, when you

    purchase Dynacord exosomes you are purchasing with confidence. Confidence that the product you buy matches the contents in the certificate of analysis (COA) EVERY TIME

    Request a Free Consultation